(Q39320362)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760522%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Dipyridamole prevents triple-negative breast-cancer progression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760522%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760522%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Luigi Navas

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760522%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Massimo Zollo

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760522%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

3

Natascia Marino

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760522%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

8

Valeria Di Dato

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760522%20AND%20SRC:MED&resulttype=core&format=json

Maria Nunzia Scoppettuolo

6 February 2020

6

object named as

Maria Nunzia Scoppettuolo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760522%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

11

Chiara Medaglia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760522%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

10

Gennaro De Vita

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760522%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Daniela Spano

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760522%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Jean-Claude Marshall

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760522%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Daniela De Martino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760522%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Alessia Romano

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760522%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Patricia S Steeg

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760522%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

4 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760522%20AND%20SRC:MED&resulttype=core&format=json

Clinical & Experimental Metastasis

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760522%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760522%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760522%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

47-68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760522%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Tumor metastasis: mechanistic insights and clinical challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Dipyridamole, an underestimated vascular protective drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Nucleoside transport in normal and neoplastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Modulation of RTX cytotoxicity by thymidine and dipyridamole in vitro: implications for chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Potentiation of cytotoxicity of mitoxantrone toward CHO-K1 cells in vitro by dipyridamole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Nucleoside transport inhibitors, dipyridamole and p-nitrobenzylthioinosine, selectively potentiate the antitumor activity of NB1011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Dipyridamole increases the cytotoxicity of cisplatin in human larynx cancer cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

BCRP transports dipyridamole and is inhibited by calcium channel blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Review of the ESPRIT Study: Aspirin plus Dipyridamole versus Aspirin Alone for Prevention of Vascular Events after a Noncardioembolic, Mild-to-Moderate Ischemic Stroke or Transient Ischemic Attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Platelet aggregation in the formation of tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Phase II trial of infusional fluorouracil, leucovorin, mitomycin, and dipyridamole in locally advanced unresectable pancreatic adenocarcinoma: SWOG S9700.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Inhibition of breast cancer metastasis by dual liposomes to disturb complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Inhibition of pulmonary metastasis in a human MT3 breast cancer xenograft model by dual liposomes preventing intravasal fibrin clot formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Triple-Negative Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Microelectronic cell sensor assay for detection of cytotoxicity and prediction of acute toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Evaluation of anti-Wnt/β-catenin signaling agents by pGL4-TOP transfected stable cells with a luciferase reporter system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

The first five years of the Wnt targetome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Dipyridamole selectively inhibits inflammatory gene expression in platelet-monocyte aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Redox state of dipyridamole is a critical determinant for its beneficial antioxidant and antiinflammatory effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Pinitol targets nuclear factor-kappaB activation pathway leading to inhibition of gene products associated with proliferation, apoptosis, invasion, and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Transcriptional activation of survivin through the NF-kappaB pathway by human T-cell leukemia virus type I tax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Molecular Pathways Linking Inflammation and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

S100A4 and metastasis: a small actor playing many roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Signal transduction mechanisms involved in S100A4-induced activation of the transcription factor NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Selective intraperitoneal biochemical modulation of methotrexate by dipyridamole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Phase I and pharmacokinetic trial of intraperitoneal etoposide in combination with the multidrug-resistance-modulating agent dipyridamole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

MAP kinases and cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

The NF-κB/AKT-dependent Induction of Wnt Signaling in Colon Cancer Cells by Macrophages and IL-1β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

A hidden oncogenic positive feedback loop caused by crosstalk between Wnt and ERK pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Protein-protein interactions in the regulation of the extracellular signal-regulated kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Nuclear factor-kappaB in cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9506-0

Changes of the hepatic proteome in hepatitis B-infected mouse model at early stages of fibrosis

21 January 2018

1 reference

12 December 2020

The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer

1 reference

12 December 2020

Phase I clinical trial of a combination of dipyridamole and acivicin based upon inhibition of nucleoside salvage

1 reference

12 December 2020

Circumvention of adriamycin resistance by dipyridamole analogues: a structure-activity relationship study

1 reference

12 December 2020

Enhancement of methotrexate cytotoxicity towards the MDA.MB.436 human breast cancer cell line by dipyridamole. The role of methotrexate polyglutamates

1 reference

12 December 2020

Potentiation of methotrexate toxicity by dipyridamole.

1 reference

12 December 2020

Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Cancer Treatment Group Trial

1 reference

12 December 2020

1 reference

12 December 2020

Phase I trial of dipyridamole with 5-fluorouracil and folinic acid

1 reference

12 December 2020

Differentially potentiating effects by dipyridamole on cytotoxicity of 5-fluorouracil against three human maxillary cancer cell lines derived from a single tumor

1 reference

12 December 2020

Comparison of the synergistic potentiation of etoposide, doxorubicin, and vinblastine cytotoxicity by dipyridamole

1 reference

12 December 2020